Stock DALS DA32 LIFE SCIENCE TECH ACQUISITION CORP.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

All News DA32 Life Science Tech Acquisition Corp.

Equities

DALS

US23312M1062

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
DA32 Life Science Tech Acquisition Corp.(NasdaqCM:DALS) dropped from NASDAQ Composite Index
CI
DA32 Life Science Tech Acquisition to Redeem All Shares
MT
DA32 Life Science Tech Acquisition Corp. Announces Redemption of Shares
BU
DA32 Life Science Tech Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
DA32 LIFE SCIENCE TECH ACQUISITION CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-K)
AQ
DA32 Life Science Tech Acquisition Corp. Auditor Raises 'Going Concern' Doubt
CI
DA32 LIFE SCIENCE TECH ACQUISITION CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
DA32 Life Science Tech Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
DA32 LIFE SCIENCE TECH ACQUISITION CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
DA32 Life Science Tech Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
DA32 LIFE SCIENCE TECH ACQUISITION CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
DA32 Life Science Tech Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
DA32 Life Science Tech Acquisition Corp. Reports Earnings Results for the Eight Months Ended December 31, 2021
CI
DA32 LIFE SCIENCE TECH ACQUISITION CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-K)
AQ
Certain Class B Common Stock of DA32 Life Science Tech Acquisition Corp. are subject to a Lock-Up Agreement Ending on 23-JAN-2022.
CI
DA32 LIFE SCIENCE TECH ACQUISITION CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
DA32 LIFE SCIENCE TECH ACQUISITION CORP. : Other Events (form 8-K)
AQ
DA32 Life Science Tech Acquisition Corp. : Sponsored by Deerfield, ARCH Venture Partners and Section 32, Announces Closing of $200 Million Initial Public Offering
BU
DA32 LIFE SCIENCE TECH ACQUISITION CORP. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other Events (form 8-K)
AQ
DA32 Life Science Tech Acquisition Corp. Announces Executive Changes
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. DALS Stock
  4. News DA32 Life Science Tech Acquisition Corp.